INTERVIEW: Celgene's head dealmaker strikes a fair balance

Celgene is known among biotechnology firms for being a disciplined buyer and an ideal collaborator – a reputation in which the company's head dealmaker George Golumbeski takes a lot of pride.

More from Anticancer

More from Therapy Areas